Pioneering Hospitals Take Major Steps Towards Decarbonizing Healthcare with Philips

Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower cost

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced significant greenhouse gas (GHG) emissions reduction results following collaboration with customers worldwide to assess and mitigate their carbon footprints, while also enhancing patient care and customer operational efficiency. Key achievements include:

  • Jackson Health System (US): A 47% projected reduction in CO2e emissions by replacing legacy patient monitors, comprising 508-tons equipment lifecycle CO2e reduction and 177 tonnes CO2e reduction due to battery and paper savings.
  • Champalimaud Foundation (Portugal): 24% emissions reduction per exam in its radiology and nuclear medicine department, with a goal to halve the carbon footprint of its diagnostic and interventional imaging departments by 2028.
  • Rennes University Hospital (France): Opportunities identified to reduce annual emissions of the cath lab through energy savings and sustainable equipment upgrades.
  • County Durham and Darlington NHS Foundation Trust (UK): A sustainability blueprint developed for the trust’s ICU, focusing on waste reduction and energy efficiency.

“Good healthcare has to be environmentally sustainable, which means words and good intentions urgently need to be turned into positive actions. Philips is committed to co-creating solutions that drive measurable, impactful change. By working with like-minded action leaders around the world, sharing with them our expertise in sustainable healthcare operations, we are helping them to take critical and tangible steps toward a greener future, while at the same time enhancing patient care,” said Robert Metzke, Global Head of Sustainability at Philips.

Examples of projects based on a comprehensive ‘360-degree’ holistic life cycle assessment (LCA) of a hospital organization’s sustainability, together with more detail about key results [1] include:

Jackson Health System (Miami, Florida, US)
Philips conducted a retrospective Life Cycle Assessment of patient monitoring at 3 of Jackson Health System’s hospitals revealing that by switching to the Philips monitoring platform from their previous provider, over a 10-year period, they may be able to reduce carbon emission from patient monitoring by 47%. Data from the LCA assessment indicated that the Philips IntelliVue and EarlyVue monitors can help reduce the health system’s patient monitoring carbon footprint by 508 tons of CO2e across all facets of the lifecycle. Battery and paper savings reduced CO2e by an additional 177.1 tons.  This significant reduction also eliminates the need for an estimated 420,000 disposable AA batteries and 6.5 million sheets of paper, which can allow the health system to save $1.2 million over a 10-year device lifetime.

Champalimaud Foundation (Lisbon, Portugal)
In March 2023, Philips and Champalimaud Foundation, a leader in translational biomedical research and clinical care, entered into a strategic partnership aimed at halving the carbon footprint of Champalimaud’s diagnostic and interventional imaging departments by 2028. Potential reductions associated with equipment replacement and usage over the 5-year period were calculated and a replacement plan put into action. Based on a comprehensive LCA, the baseline carbon footprint of the existing imaging equipment was 2,175 tonnes CO2e. The collaboration achieved a 24% reduction in CO2e emissions per exam in the first year, primarily through EcoDesign equipment replacement and incorporating circular practices.
Read the full case study here.

Rennes University Hospital (Rennes, France)
Part of a five-year technology, research, and innovation partnership, this project aimed to decarbonize and reduce the overall environmental impact of Rennes University Hospital’s catheterization laboratory (cath lab), in which a Philips Image Guided Therapy System – Azurion – is used to treat strokes and aneurysms. Conducted in accordance with the latest European Union Product Environmental Footprint guidelines, a LCA of the carbon footprint and other pollutants associated with Azurion and the consumables used during interventional procedures revealed opportunities to reduce the lab’s annual emissions through energy savings, circular upgrades, and refurbishment. The assessment also identified opportunities to reduce the rare metal content of equipment and consumables.
Read the full case study here.

County Durham and Darlington NHS Foundation Trust (Darlington, UK)
Philips partnered with County Durham and Darlington NHS Foundation Trust (CDDFT) to identify key opportunities to reduce greenhouse gas emissions and materials waste in the intensive care unit (ICU) at Darlington Memorial Hospital. Key areas highlighted by the team for enhancing sustainable ICU care included patient discharge optimization, waste reduction in the supply chain, staff training to encourage knowledge sharing and a sustainability culture, energy reduction and materials waste associated with ICU equipment, and the strategic refurbishment of buildings to reduce their emissions. The results formed a blueprint to drive further change and improvement across the Trust, in line with the UK NHS’s target of being the world’s first net zero national health service by 2040.
Read the full case study here.

Vanderbilt University Medical Center (Nashville, US)
In collaboration with leading sustainability experts at Vanderbilt University Medical Center, Philips collaborated in a LCA project to measure and mitigate emissions associated with an entire radiology department. The results revealed that 10-year emissions from Vanderbilt’s current diagnostic radiology unit amounted to 4,600 tonnes CO2e, primarily associated with lifecycle emissions from its MR imaging suite (48%) and CT imaging suite (24%). Key mitigation recommendations for radiology departments included accelerating digitization, embracing circularity, and transitioning to renewable energy sourcing. Recommendations for health technology companies included designing for energy reduction, applying circular design principles, and developing smart image storage.

Philips is driving sustainable and equitable healthcare

Philips recognizes the link between human and environmental health, with healthcare systems responsible for over 4% of global CO2 emissions [2] and significant materials usage. As part of Philips’ broader ESG commitments, Philips is driving the transition towards sustainable and equitable healthcare to deliver better care for more people. The company has been carbon neutral in its own operations since 2020. All new product introductions are designed in line with the company’s EcoDesign requirements by 2025, and it aims to generate 25% of its revenue from circular products and services by 2025. Societally, it aims to improve the health and well-being of 2 billion people per year by 2025, including 300 million people in underserved communities, and 1 million workers in its supply chain.

References

[1] Results from case studies are not predictive of results in other cases.
– Jackson and Health System: The LCA results are obtained using Philips Environmental Profit & Loss (EP&L), proxy data, literature and customer obtained data. The LCA is not validated externally by 3rd party.

– Champalimaud Foundation and Rennes CHU: The LCA results are obtained using Philips Environmental Profit & Loss (EP&L), proxy data, literature and customer obtained data including energy measurements. The LCAs are validated externally by 3rd party.

[2] EDGAR—Emissions Database for Global Atmospheric Research Emissions Data and Maps 2018 http://edgar.jrc.ec.europa.eu/

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.